IVF add-ons: asking about evidence and meaningful benefit

An IVF add-on should answer a specific question: what benefit might it offer someone with your treatment history, and how reliably is that known? A long list of technologies in a package does not establish that each increases the chance of a baby. Before agreeing, request a separate explanation of the purpose, limitations, risks and cost of every proposed addition.

Read a claim of a “20% improvement” carefully

A percentage without a starting value can be misleading. As an arithmetic illustration, not treatment data, increasing from 10 to 12 outcomes per 100 observations is a 20% relative increase but a 2-percentage-point absolute increase. Both descriptions concern the same numbers and create different impressions. A real study also needs a clear outcome, group size and account of uncertainty.

Before deciding, ask for the starting chance, the expected absolute difference and whether the evidence applies to your patient group. If no reliable estimate exists, that gap should not be filled with a promotional promise. The discussion can still explain what is known and what remains unresolved.

Clarify what “success” means: an intermediate laboratory change, pregnancy or the birth of a baby. It is easy to consider paying for an addition with one goal in mind while being shown statistics about another. An agreed outcome helps assess the proposal on its merits and distinguish personal hopes from the strength of evidence.

Identify the method and the intended outcome

Write down the full name of the test or procedure. Marketing names can cover different methods, and similar abbreviations can refer to different actions. Clarify whether the proposal is an additional investigation, a laboratory technique or a treatment.

Ask which outcome is expected to improve. A better intermediate laboratory measurement does not necessarily demonstrate an increased likelihood of live birth. If a proposal refers to improved quality, ask how quality was measured and whether it was linked to the outcome that matters to patients.

Ask whom the evidence concerns

HFEA publishes evidence assessments for a range of fertility add-ons. Those assessments relate to particular methods and patient groups; a finding about one technique should not be transferred to every other addition. Ask about research relevant to your circumstances and how certain the conclusions are.

It helps to distinguish a lack of reliable evidence, evidence of no benefit and evidence of possible harm. These are different findings. A clinician should not be pressed to promise certainty where knowledge is limited, but the uncertainty should be explained clearly enough to support a decision.

Compare the plan without the add-on

Ask the team to describe the main treatment plan without the proposed extra. Would timing, workload, cost or the ability to proceed change? Establish whether the procedure is needed for a stated medical reason or is an optional choice.

After an unsuccessful cycle, wanting to change everything is understandable. However, adding several methods simultaneously can make a later outcome harder to interpret. Ask which observations from the earlier cycle support each proposed change and which changes are based mainly on an uncertain expectation.

Include burdens, risks and consent

Even when a procedure is presented as simple, ask about possible adverse effects, extra appointments, delay to the main treatment and required samples. If embryos are involved, discuss the laboratory process and its limitations. Consent to a particular addition should not disappear inside an unexplained signature for an entire package.

Request the information beforehand in a language you understand. Ask whether you can decline the addition and how that would affect the main quotation. The additional cost should be separately visible, so the clinical choice and the financial implications can both be assessed.

Keep a short record of the decision

Record the method, proposed outcome, relevant patient group, main limitations of the evidence and your decision after the consultation. Keep the clinic’s dated information because knowledge and available methods change. HFEA resources can help you formulate questions; they do not confirm that a particular procedure is available at a Turkish clinic or appropriate for you.

To compare the main plan and separate additions, see comparing treatment proposals.

Sources

Medicina Turkey patient information. General guidance; individual medical decisions should be discussed with the treating clinician.